PRA Health Sciences expands COVID-19 monitoring program
The CRO is working with PWNHealth and Fulgent Genetics to enhance its monitoring program, including the addition of at-home COVID-19 testing capabilities.
Archives for January 11, 2021
Lexaria broadens COVID-19 drug exploration program
The drug delivery platform company is exploring the viability of remdesivir and other potential treatments for the virus using its DehydraTECH technology.